Cargando…

Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach

Oncology is currently a sector of medical science with accelerated progress due to rapid technological development, the advancement in molecular biology, and the invention of many innovative therapies. Immunotherapy partially accounts for this advance, since it is increasingly playing an important r...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikolaou, Michail, Nikolaou, Georgios, Digklia, Antonia, Pontas, Christos, Tsoukalas, Nikolaos, Kyrgias, George, Tolia, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242802/
https://www.ncbi.nlm.nih.gov/pubmed/30791740
http://dx.doi.org/10.1177/1534735419827090
_version_ 1783537302134325248
author Nikolaou, Michail
Nikolaou, Georgios
Digklia, Antonia
Pontas, Christos
Tsoukalas, Nikolaos
Kyrgias, George
Tolia, Maria
author_facet Nikolaou, Michail
Nikolaou, Georgios
Digklia, Antonia
Pontas, Christos
Tsoukalas, Nikolaos
Kyrgias, George
Tolia, Maria
author_sort Nikolaou, Michail
collection PubMed
description Oncology is currently a sector of medical science with accelerated progress due to rapid technological development, the advancement in molecular biology, and the invention of many innovative therapies. Immunotherapy partially accounts for this advance, since it is increasingly playing an important role in the treatment of cancer patients, bringing on a sense of hope and optimism through a series of clinical studies and cases with spectacular results. Immunotherapy, after the initial successes it experienced in the early 20th century, was forgotten after chemotherapy and radiotherapy prevailed and developed slowly in the background. Today, it is the new hope for cancer treatment, despite the unorthodox path it has followed. In this article, we study the course and key points of the discovery of immune-oncology from the oncologist’s point of view. We also record the questions that have been posed about immunotherapy that sometimes lead to confusion or stalemate.
format Online
Article
Text
id pubmed-7242802
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-72428022020-06-03 Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach Nikolaou, Michail Nikolaou, Georgios Digklia, Antonia Pontas, Christos Tsoukalas, Nikolaos Kyrgias, George Tolia, Maria Integr Cancer Ther Review Article Oncology is currently a sector of medical science with accelerated progress due to rapid technological development, the advancement in molecular biology, and the invention of many innovative therapies. Immunotherapy partially accounts for this advance, since it is increasingly playing an important role in the treatment of cancer patients, bringing on a sense of hope and optimism through a series of clinical studies and cases with spectacular results. Immunotherapy, after the initial successes it experienced in the early 20th century, was forgotten after chemotherapy and radiotherapy prevailed and developed slowly in the background. Today, it is the new hope for cancer treatment, despite the unorthodox path it has followed. In this article, we study the course and key points of the discovery of immune-oncology from the oncologist’s point of view. We also record the questions that have been posed about immunotherapy that sometimes lead to confusion or stalemate. SAGE Publications 2019-01-30 /pmc/articles/PMC7242802/ /pubmed/30791740 http://dx.doi.org/10.1177/1534735419827090 Text en © The Author(s) 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review Article
Nikolaou, Michail
Nikolaou, Georgios
Digklia, Antonia
Pontas, Christos
Tsoukalas, Nikolaos
Kyrgias, George
Tolia, Maria
Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach
title Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach
title_full Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach
title_fullStr Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach
title_full_unstemmed Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach
title_short Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach
title_sort immunotherapy of cancer: developments and reference points, an unorthodox approach
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242802/
https://www.ncbi.nlm.nih.gov/pubmed/30791740
http://dx.doi.org/10.1177/1534735419827090
work_keys_str_mv AT nikolaoumichail immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach
AT nikolaougeorgios immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach
AT digkliaantonia immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach
AT pontaschristos immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach
AT tsoukalasnikolaos immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach
AT kyrgiasgeorge immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach
AT toliamaria immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach